Better care starts with new tools.

DotEndoTM is a first-of-its-kind blood test that aids in the diagnosis of active endometriosis.

DotLab | Real Patients with Endometriosis

DotEndo is now available to select healthcare providers.

DotEndo is a non-invasive test that applies an algorithm to the differential expression levels of endometriosis-specific microRNA biomarkers in the blood, to provide a dichotomous result indicative of the presence or absence of endometriosis.

Unexplained Infertility

Understand if endometriosis is a root cause of unexplained infertility

Pelvic Pain or Dysmenorrhea

Determine if endometriosis is behind the symptoms from multiple gynecological issues

Treatment Plan Uncertainty

Increase confidence to proceed with endometriosis-specific treatment

DotEndo is the first-of-its-kind blood test for endometriosis, and is now available to select providers. Clinicians can sign up to be notified when the test is available in their area.

Sign up
illustrative product box

The easy, trusted, and safe way to test for endometriosis.

Hand holding circleHand holding circle
Order DotEndo tests and either keep inventory in your office or have it sent directly to your patients.
Test tube
Patient provides sample and sends to DotLab in the pre-paid mailer included in the box.
Clock
Receive actionable results directly in the DotLab physician portal within ten days.
Swinging pendulum

Our data published in American Journal of Obstetrics and Gynecology demonstrated that microRNAs reliably differentiated between endometriosis and other gynecologic pathologies, such as fibroids, with high accuracy (AUC > 0.9) across two independent sample sets.

Sign up to receive important announcements and updates:
DotLab will never share your information with third parties. We respect your privacy. We will only use this information to contact you. See our Privacy Policy for more information about how we collect and use personal data.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.